Seroprevalence of IgM and IgG Antibodies against SARS-CoV-2 in Asymptomatic People in Wuhan: Data from a General Hospital Near South China Seafood Wholesale Market during March to April in 2020.
- Author:
Rui Jie LING
1
;
Yi Han YU
1
;
Jia Yu HE
2
;
Ji Xian ZHANG
1
;
Sha XU
1
;
Ren Rong SUN
1
;
Wang Cai ZHU
1
;
Ming Feng CHEN
2
;
Tao LI
2
;
Hong Long JI
3
;
Huan Qiang WANG
2
Author Information
- Publication Type:Letter
- Keywords: COVID-19; Computed tomography; IgG; IgM; SARS-CoV-2; Serological testing; Seroprevalence
- MeSH: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Viral/blood*; COVID-19/immunology*; Carrier State/immunology*; Child; Child, Preschool; China/epidemiology*; Coronavirus Nucleocapsid Proteins/immunology*; Cross-Sectional Studies; Female; Humans; Immunoglobulin G/blood*; Immunoglobulin M/blood*; Male; Middle Aged; Occupations/classification*; Phosphoproteins/immunology*; SARS-CoV-2/immunology*; Seroepidemiologic Studies; Spike Glycoprotein, Coronavirus/immunology*; Young Adult
- From: Biomedical and Environmental Sciences 2021;34(9):743-749
- CountryChina
- Language:English
- Abstract: The aim of this study was to estimate the seroprevalence of immunoglobulin M (IgM) and G (IgG) antibodies against SARS-CoV-2 in asymptomatic people in Wuhan. This was a cross-sectional study, which enrolled 18,712 asymptomatic participants from 154 work units in Wuhan. Pearson Chi-square test,
